Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Using Microbiome to Predict Durvalumab Toxicity in Post- Concurrent Chemoradiation Therapy (CCRT) NSCLC Patients
Apply
Durvalumab
Using Microbiome to Predict Durvalumab Toxicity in Post- Concurrent Chemoradiation Therapy (CCRT) NSCLC Patients
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step